journal article·2025-11

Natural Tannin and Upconversion Photons Co‐Potentiate Fe Fenton Anticancer Therapy

Jiawei Qu, Chunsheng Li, Jiating Xu, Shuang Liu, Qiang Wang, Zhengyang Tang, Hao Sun, Jian Liang, Ping'an Ma, Piaoping Yang, Xinglu Zhou

Advanced Functional Materials· Volume 35· Issue 47
Publisher page

Abstract

Abstract Chemodynamic therapy (CDT) is a tumor‐specific catalytic therapeutic modality that harnesses metal ion‐mediated Fenton/Fenton‐like reactions within H 2 O 2 ‐overexpressed tumor tissues for anticancer purposes. However, their efficacy is limited by the low recycling rate of high‐ and low‐valence metal ions. Herein, a Fe 2+ self‐supplied nano‐platform (CSFT) is developed for near‐infrared (NIR)‐accelerated photo‐Fenton CDT synergized with photothermal therapy, magnetic resonance imaging (MRI), and second near‐infrared (NIR‐II) imaging. Specifically, a CSFT nano‐platform is synthesized by coating metal‐coordinated polyphenol networks composed of Fe 3+ and tannic acid (Fe‐TA) onto the surfaces of Er 3+ , Ce 3+ , and Tm 3+ co‐doped core‐shell nanoparticles. At an optimal Tm 3+ doping content (1%), the upconversion (UC) ultraviolet signal of the core‐shell nanoparticles is enhanced by 8.2‐fold compared to that of the core, providing potential excitation energy for UC‐driven photo‐Fenton reactions and improving the Fe 3+ ‐to‐Fe 2+ conversion efficiency. Additionally, Fe‐TA can absorb NIR photons and convert them into thermal energy, enhancing the photo‐Fenton reaction and enabling photothermally enhanced CDT. The strong coordination effect of TA enables the 3d 5 electronic reorganization of Fe 3+ after their release from Fe‐TA networks in acidic tumors, thus realizing tumor‐specific self‐enhanced MRI. This work demonstrates an NIR‐promoted photo‐Fenton platform through the engineering of metal‐polyphenol networks on UC nanoparticles.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence Properties of Advanced Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Forest Plant Ecology Ministry of Education College of Chemistry Chemical Engineering and Resource Utilization Northeast Forestry University Harbin 150040 P. R. China

Heilongjiang Provincial Key Laboratory of Ecological Utilization of Forestry‐Based Active Substances Northeast Forestry University Harbin 150040 P. R. China

Department of Breast Surgery Sixth Affiliated Hospital of Harbin Medical University Harbin 150023 P. R. China

State Key Laboratory of Rare Earth Resource Utilization Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun 130022 China

Key Laboratory of Superlight Materials and Surface Technology Ministry of Education College of Material Sciences and Chemical Engineering Harbin Engineering University Harbin 150001 P. R. China

Department of PET/CT Center Harbin Medical University Cancer Hospital Harbin 150081 P. R. China

Funding

National Key Research and Development Program of China · Higher Education Discipline Innovation Project · National Natural Science Foundation of China

References (60)

Show source-provided references
1. 10.1002/adfm.20210024310.1002/adfm.202100243 ↗
2. 10.1021/jacs.0c0560410.1021/jacs.0c05604 ↗
3. 10.1002/anie.20180566410.1002/anie.201805664 ↗
4. 10.1016/j.nantod.2020.10094610.1016/j.nantod.2020.100946 ↗
5. 10.1002/anie.20221840710.1002/anie.202218407 ↗
6. 10.1016/j.cej.2021.12923810.1016/j.cej.2021.129238 ↗
7. 10.1021/acsnano.8b0586010.1021/acsnano.8b05860 ↗
8. 10.1016/j.cej.2023.14296010.1016/j.cej.2023.142960 ↗
9. 10.1016/j.cej.2021.13393210.1016/j.cej.2021.133932 ↗
10. 10.1016/j.cej.2019.12363610.1016/j.cej.2019.123636 ↗
11. 10.1021/acs.est.9b0568210.1021/acs.est.9b05682 ↗
12. 10.1002/adfm.20230146210.1002/adfm.202301462 ↗
13. 10.1021/acsnano.0c0008210.1021/acsnano.0c00082 ↗
14. 10.1016/j.cej.2022.13563710.1016/j.cej.2022.135637 ↗
15. 10.1021/acs.nanolett.0c0050210.1021/acs.nanolett.0c00502 ↗
16. 10.1021/acsnano.8b0560210.1021/acsnano.8b05602 ↗
17. 10.1038/s41377-022-00871-z10.1038/s41377-022-00871-z ↗
18. 10.1039/D2TB02273G10.1039/D2TB02273G ↗
19. 10.1021/acsami.2c2226010.1021/acsami.2c22260 ↗
20. 10.1038/s41467-021-26655-410.1038/s41467-021-26655-4 ↗
21. 10.1016/j.biomaterials.2017.06.03510.1016/j.biomaterials.2017.06.035 ↗
22. 10.1021/acsnano.2c0870610.1021/acsnano.2c08706 ↗
23. Gao G. · Adv. Funct. Mater. · 2021 · 31
24. 10.3390/ijms2212649310.3390/ijms22126493 ↗
25. 10.3390/biomedicines1001018910.3390/biomedicines10010189 ↗
26. 10.1002/anie.20131113610.1002/anie.201311136 ↗
27. 10.1002/adma.20200735610.1002/adma.202007356 ↗
28. 10.1002/anie.20180780410.1002/anie.201807804 ↗
29. 10.1016/j.cclet.2022.05.05610.1016/j.cclet.2022.05.056 ↗
30. 10.1021/acsanm.4c0544910.1021/acsanm.4c05449 ↗
31. 10.1016/j.cej.2020.12662910.1016/j.cej.2020.126629 ↗
32. 10.1002/advs.20220329210.1002/advs.202203292 ↗
33. Meng M. · Nano Lett. · 2024 · 24
34. 10.1002/adhm.20230360410.1002/adhm.202303604 ↗
35. 10.1021/acs.molpharmaceut.0c0032110.1021/acs.molpharmaceut.0c00321 ↗
36. 10.1039/C5RA16004A10.1039/C5RA16004A ↗
37. 10.1002/anie.20231188310.1002/anie.202311883 ↗
38. 10.1021/acsami.1c2281610.1021/acsami.1c22816 ↗
39. 10.1038/s41566-022-01101-z10.1038/s41566-022-01101-z ↗
40. 10.1021/nn302972r10.1021/nn302972r ↗
41. 10.1021/acsami.6b0285610.1021/acsami.6b02856 ↗
42. 10.1021/acs.nanolett.4c0348610.1021/acs.nanolett.4c03486 ↗
43. 10.1002/anie.20221626910.1002/anie.202216269 ↗
44. 10.1007/s12274-017-1555-x10.1007/s12274-017-1555-x ↗
45. 10.1038/s41467-017-00917-610.1038/s41467-017-00917-6 ↗
46. 10.1016/j.saa.2020.11928110.1016/j.saa.2020.119281 ↗
47. 10.1021/ja108948z10.1021/ja108948z ↗
48. 10.1021/acsnano.2c1287410.1021/acsnano.2c12874 ↗
49. 10.1021/acs.macromol.6b0210610.1021/acs.macromol.6b02106 ↗
50. 10.1021/acsnano.2c0515210.1021/acsnano.2c05152 ↗
51. 10.1016/j.cis.2020.10226710.1016/j.cis.2020.102267 ↗
52. Zhu G. · Adv. Mater. · 2024 · 36
53. 10.1002/adhm.20230051610.1002/adhm.202300516 ↗
54. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
55. 10.1016/j.ccr.2020.21343210.1016/j.ccr.2020.213432 ↗
56. 10.1021/jacs.4c1357310.1021/jacs.4c13573 ↗
57. 10.1038/s41580-020-00324-810.1038/s41580-020-00324-8 ↗
58. 10.1038/s41422-020-00441-110.1038/s41422-020-00441-1 ↗
59. 10.1002/anie.20241180210.1002/anie.202411802 ↗
60. 10.1038/cdd.2009.19510.1038/cdd.2009.195 ↗